Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application
Abstract
Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma.
Background: Pregnant women have a risk of exposure to gestational diabetes mellitus. The first step that can be done is to detect the risk of gestational diabetes mellitus. The aim study to access the description of the prevalence of gestational diabetes mellitus risk.
Method: The study design was descriptive with a cross sectional approach. This involved 70 pregnant women who were selected by purposive sampling. Data collection using the D3MG application.
Results: The prevalence of gestational diabetes mellitus risk were BMI â ¥ 30 kg / m2 as 2.7% (OR = 5.600; 95% CI = 1.729 - 18.141), family history 8.6% (OR = 7.308; 95% CI = 0.806 - 66.231), history giving birth to dead babies and abortion 20% (OR = 0.304; 95% CI = 0.204 - 0.451), low physical activity before pregnancy 54.3% (OR = 2.718; 95% CI = 1.016 - 7.268), low physical activity during pregnancy 95.7% (OR = 4.148; 95% CI = 1.053 - 16.343), eating habits - sugary foods 4.3% (OR = 2.621; 95% CI = 0.226 - 30.328), eating habits and foods containing high cholesterol 2.9% ( OR = 0.426; 95% CI = 0.324 - 0.562), and the duration of poor sleep 24.3% (OR = 6.319; 95% CI = 1.799 - 22.203). Pregnant women who are at low risk of exposure gestational diabetes mellitus 55.7% and high risk 44.3%.
Conclusion: There are pregnant women who have a low risk of exposure gestational diabetes mellitus detected by the application D3MG, however preventive efforts must continue to be done to prevent the occurrence of gestational diabetes mellitus and improve fetal well-being.
How to Cite this Article |
Pubmed Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. SRP. 2020; 11(6): 384-391. doi:10.31838/srp.2020.6.61 Web Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. http://www.sysrevpharm.org/?mno=116266 [Access: March 29, 2021]. doi:10.31838/srp.2020.6.61 AMA (American Medical Association) Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. SRP. 2020; 11(6): 384-391. doi:10.31838/srp.2020.6.61 Vancouver/ICMJE Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. SRP. (2020), [cited March 29, 2021]; 11(6): 384-391. doi:10.31838/srp.2020.6.61 Harvard Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma (2020) Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. SRP, 11 (6), 384-391. doi:10.31838/srp.2020.6.61 Turabian Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. 2020. Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. Systematic Reviews in Pharmacy, 11 (6), 384-391. doi:10.31838/srp.2020.6.61 Chicago Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. "Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application." Systematic Reviews in Pharmacy 11 (2020), 384-391. doi:10.31838/srp.2020.6.61 MLA (The Modern Language Association) Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma. "Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application." Systematic Reviews in Pharmacy 11.6 (2020), 384-391. Print. doi:10.31838/srp.2020.6.61 APA (American Psychological Association) Style Tri Sunarsih, Reza Bintangdari Johan, Herlin Fitriani K, Kharisma (2020) Prevalence of Gestational Diabetes Mellitus Risk in Multigravida Pregnant Women Using D3MG Application. Systematic Reviews in Pharmacy, 11 (6), 384-391. doi:10.31838/srp.2020.6.61 |